WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate products, focused on the end-stage-renal-disease (ESRD) market, today announced that Robert L. Chioini, President and CEO of Rockwell, will present an overview of the Company at the JMP Securities Healthcare Focus Conference at 12:00pm EST on Tuesday, November 13, 2007. Mr. Chioini will provide investors with an overview of Rockwell and its lead renal drug therapy product, SFP.
